Documente Academic
Documente Profesional
Documente Cultură
Procesul de cercetare
este piatra fundamentala pentru luarea unor decizii eficiente si in cunostinta de cauza este parte integranta din eforturile tarilor de: a ameliora starea de sanatate a populatiei si de
a creste eficienta sistemelor sanitare, mai ales in conditii de transformari dramatice epidemiologice, demografice si economice, transformari care afecteaza profund sistemele sanitare
In aceste cursuri:
se vor descrie metodele de planificare si realizare a cercetarii stiintifice:
formularea problemelor stabilirea obiectivelor cercetarii planificarea studiului ("designing the study")
metode de colectare a datelor analiza statistica a datelor
DEFINITII (1)
cercetarea stiintifica este o descoperire a cunostintelor prin cautare sau investigatie asidua sau prin experimente avand drept scop descoperirea si interpretarea de cunostinte noi metoda stiintifica este un grup de tehnici si proceduri sistematice aplicate in cursul desfasurarii investigatiei sau experimentului si orientate catre obtinerea de noi cunostinte
DEFINITII (2)
cercetarea si metodele stiintifice pot fi considerate o cale de investigatie critica ducand la descoperirea unor fapte sau informatii care amplifica intelegerea noastra asupra sanatatii si bolilor umane
cercetarea in domeniul sanatatii utilizeaza in principal abordarea empirica adica este bazata pe:
Observatie Experienta
Mai putin bazata pe: Teorie Abstractizare
Cercetarea empirica
Cercetarea empirica in stiintele medicale poate fi:
cantitativa calitativa
2.Cercetarea Fundamentala si Aplicata(3) Exista o controversa continua cu privire la beneficiul relativ si contributia catre societate a celor doua tipuri de cercetare
3.Triunghiul Cercetarii in Domeniul Sanatatii (2) Se realizeaza astfel asa-numitul triunghi al cercetarii medicale (al cercetarii in domeniul sanatatii)
3.Triunghiul Cercetarii in Domeniul Sanatatii (3) Cercetarea biomedicala se preocupa in principal de cercetarea fundamentala implicand procesele de la nivel celular
individului in societate
in termenii logicii, aceasta inseamna ca o afirmatie sau o concluzie trebuie sa fie acceptata deoarece una sau mai multe alte afirmatii sau premize (dovezi) sunt adevarate 2. Deductia si Sansa supozitiile, prezumtiile sau teoriile deductive pot fi atat de dezvoltate, printr-o constructie atenta, incat sa devina ipoteze testabile testarea ipotezei este metoda care sta la baza avansarii cunostintelor in stiinta 3.Deductia si Sansa in dezvoltarea deductiilor s-au diferentiat doua abordari sau argumente distincte: deductiva Inductiva 4.Deductia si Sansa in deductie, in mod necesar concluzia rezulta din premize, ca de exemplu in: silogism (toate A sunt B, toate B sunt C, de aceea toate A sunt C) ecuatiile algebrice
adevarate, adica exista posibilitatea ca premizele sa fie adevarate, dar concluziile sa fie false
Deductia si Sansa (8) in gandirea inductiva (2) de aceea trebuie sa se tina seama in intregime de sansa
mai departe, gandirea inductiva se distinge prin faptul ca trece de la specific la general
3.Evaluarea si Probabilitatea(2)
cele mai importante elemente (1) ale proiectului de cercetare, elemente avand drept scop asigurarea integritatii probabilitatii si prevenirea bias-ului, sunt:
esantionul sa fie reprezentativ randomizarea in selectia grupurilor de studiu
3.Evaluarea si Probabilitatea(4)
Probabilitatea (1) este o masura a nesigurantei sau a variabilitatii caracteristicilor intre diversii indivizi ai unei populatii:
daca se va observa intreaga populatie, calcularea frecventelor relative ale variabilelor ofera toate informatiile referitoare la variabilitate
Obiective
Construire unui mod de documentare, emitere de ipoteze si testarea acestora
Dobandirea abilitatilor de cercetare
Tipuri de Studii
Nu sunt cea mai buna alegere pentru acest curs Studii fundamentale: molecule, celule, soareci Cost-eficienta, meta-analize Cercetare calitativa Ideal Un studiu observational (sau interventional) ce implica pacienti
Ipoteza de lucru
Toate studiile incep cu o problema, intrebare fara raspuns Scopul este alegerea unei intrebari de cercetare relevante, ce poate fi transformata in proiect
Problema studiului
Format pentru un studiu descriptiv
Intr-o populatie de [populatie de studiu ], care este prevalenta (sau incidenta, mortalitatea, etc.) [variabila dependenta]? Majoritatea studiilor au mai mult decat o problema de evaluat si rezolvat Protocolul de cercetare deriva din problema studiului
Problema studiului
Format uzual (studii analitice):
Intr-o populatie de [populatie de studiu], exista o asociere intre [variabila dependenta] cu [variabila independenta]?
Intr-o populatie de [populatie de studiu], exista o asociere intre [variabila dependenta] si [variabila independenta]?
In a population of South African infants is immunization with a 9-valent pneumococcal conjugate vaccine associated with invasive pneumococcal disease?
Imaginatia
Caracteristicile FINER
Criterii de Fezabilitate
Numar adecvat de subiecti Expertiza technica adecvata Realizabil ca resurse de timp si bani Resurse umane calificate adecvat
Caracteristicile FINER
Criterii de Interes
Studii cu impact populational Detalierea a noi mecanisme de boala Studii de eficienta terapeutica pentru metode noi
Nefezabil
Prea larg Prea putini pacienti disponibili Metode sofisticate, peste abilitatile dovedite de investigator Prea scump
Probleme si solutii:
Planul nu este Fezabil
Prea larg
Un set mai mic de variabile Se delimiteaza mai mult domeniul
Prea scump
Scade costurile designului de studiu
Mai putini subiecti si masuratori Detaliu mai mic al masuratorii Mai putine vizite de urmarire
Probleme si solutii
Planul de studiu este vag
Rescrie planul de cercetare mai amanuntit
Detaliaza din planul de studiu
Cum vor fi selectati subiectii si lotul martor Cum vor fi masurate variabilele
Tipuri de variabile
Variabile de confuzie*
Predictor*
Rezultat
Modificatori ai efectului*
*Considerate general ca expunere la factori de risc
Problema de studiu
In studii descriptive: Intr-o populatie de [study population], care este prevalenta [outcome variable]?
In studii analitice :
Intr-o populatie de [study population], este [predictor variable] asociata cu [outcome variable]?
Studii cu 2 variabile
Experimente Studii observationale Meta-analize si review-uri sistematice
Cohort
Case-control
Cross-sectional
Variabile
3. Aspecte etice
4. Resurse- bani, oameni, infrastructura
FINER?
Ncesitatea desing-ului
Trial clinic randomizat
Puncte finale Interes primar
Studiu observational
Cross-sectional Caz control Cohorta
Design
Definirea populatiei
Randomizare
Alocarea subiectilor
Interventie
Tratament nou
Ameliorat
Ne ameliorat
Ameliorat
Ne ameliorat
Masking (blinding)
Outcome / endpoint
improvement ( desired effect) and side effects must be explicitly defined
Multi-centre trial Comply with GCP requirements Clinical trials/ community trials
Results of RCT- benchmark- good clinical practice (GCP) , clinical governance, treatment protocol.
Types of RCT:
A B
Cross over
- Planned washout period
randomized
- Unplanned
A B
randomized
B A
Medical
Require surgery No surgery
Surgical
Refuse surgery Surgery
Limite
1. ? Eficienta n comunitati necontrolate 2. Refuzul consimmntului informat - selectare automat (persoane care particip sunt diferite de cele care nu o fac) 3. Necomplianta (persoanele compliante sunt foarte diferite de cele care nu sunt) - Drop-out: nu adera la regim experimental, pierderea din studiu - Drop-in: nu adera la regimul de control 4. Complianta- necesita monitorizare 5. Cele mai costisitoare tipuri de studii
Studii observationale
1. Cohort study 2. Case-control study 3. Cross sectional study 4. Ecologic or trend study 5. Case report or series 6. Qualitative research
Studiu de cohorta
Subiecti
5000 femei cu varsta 55+ ani
Factor predictor:
estrogeni post-menopausal?
Outcome:
Incidenta accidentelor coronariene dupa 5 ani de terapie
Cohorta
Cohorta: "orice grup desemnat de persoane care sunt urmrite pe o perioad de timp
Cazurile selectate in cohorta trebuie sa fie fara boala cercetata la nceputul urmaririi (populaia la risc) De obicei cohorta este definita sau submprita n funcie de statutul de expunere
Populatia la risc
All subjects within a cohort must be free of the outcome at the start of the follow-up period
All subjects must be at risk for developing the disease (population at risk)
Retrospective
Control mai slab al calitii i cantitii de date Potenial mai mare de eroare Mai rapide Mai ieftine
Start with exposure, then follow to see whether Incidence rate total Disease + Disease of disease Exposed + a b a+b
a/a+b
Exposed -
c+d
c/c+d
Riscul absolut = incidena cazurilor de boal n lotul expus / populaia total Riscului relativ =
Incidenta bolii la E+ Incidenta bolii la E-
Limite
Unele expuneri la risc se pot modifica n timp ex mbtrnire, stilul de via (diet, fumat), expunerea la produse farmaceutice, poluarea aerului Modificri privind metoda de-a lungul timpului, identificarea bolii Prospectiv - follow-up, deci cu perioade lungi Costisitor Potential de eroare: eroare de selecie (care subiect a fost expus i care nu) eroare de anamneza - date istorice eroare n evaluarea rezultatelor eroare prin lipsa de rspuns i pierdere la f / u eroare analitic
Cross-sectional design
Subiecti
2000 femei varsta 55+ ani
Predictor:
Tratament post-menopausal cu estrogeni?
Rezultat:
Istoric de accident coronarian?
Generally efficient but large scale community survey can be expensive. Sometimes survey data given causal interpretation (pseudo-longitudinal) but liable to error, caution.
Design Case-control
Subiecti / femei la menopauza
Cazuri: 100 femei cu accident coronarian Controale: 100 femei fara patologie cardiaca
Predictor:
Au luat estrogeni post-menopauza?
Rezultate:
Cazuri vs controale
Controls
Case Control Studies compare exposure history of cases and controls Controls provide exposure distribution of exposure (exposed and unexposed cohorts) in source population that gave rise to the cases in the study Biggest Problem: Identifying an appropriate control group
Random-Digit Dialing
Hospital-Based Controls
Traditionally, Nested Case Control Study usually refers to study that are conducted within the experience of a well-defined cohort study
a
c a/a+c
b
d b/b+d
a+b
c+d
Etic?
Echivalenta (nu este sigur daca domina beneficii sau riscuri) Beneficii ale terapiei de substitutie Scad simpotomele de climax ? Preventia fracturilor ? Preventia BCI ? Preventia Alzheimer ? Cresterea calitatii vietii
Relevant?
Estrogeni / estroprogestative Decizia afecteaza o mare parte din populatie
TRECUT
A primit HRT?
PREZENT
Cancer mamar
No
Yes Cazuri
No
Yes Controale
Bias
Age standardized death rate per 1000 Quantity of salt sold at Henan province in China
Qualitative research :
Development of concepts which help us to understand social phenomena in natural settings, giving due emphasis to the meanings, experiences, and views of all the participants It does not primarily seek to provide quantified answers to research questions Particularly useful for explaining complex phenomena not amenable to quantitative research
Plan de studiu
Problema cercetata Semnificatie (background) Designul studiului Populatia de studiu si esantionarea Variabile si masuratori Elemente statistice
Care sunt subiectii si cum sunt selectati? Ce masuri vor fi luate? Dimensiunea lotului si analiza? Aspecte etice Exista probleme etice? Controlul calitatii si evaluarea Cum se asigura controlul calitatii datelor datelor si analizei acestora?
Fond si semnificatie
Bazat pe experienta
Fond si semnificatie
Citarea cercetarilor relevante anterioare (inclusiv propriile date)
Indica punctele forte si slabe ale studiilor anterioare, ca si intrebarile ramase fara raspuns. Arata cum vor fi folosite rezultatele studiului propus pentru rezolvarea neclaritatilor si influentarea politicii de sanatate sau practicii clinice
Obiective
Stabilirea tipurilor de variabile
Surse IT de date Identifica si localizeaza seturile corecte de date
In institutie In afara institutiei
Strategii de masurare
Analiza, interpretarea si raportarea rezultatelor
Selecteaza programul adecvat: Excel, SPSS Foloseste programele pentru analize statistice simple si prezentarea grafica a rezultatelor Interpreteazarezultatele
Tipuri de variabile
Variabile de confuzie*
Predictor*
Rezultat
Modificatori ai efectului*
*Considerate general ca expunere la factori de risc
Studii cu 2 variabile
Experimente Studii observationale Meta-analize si review-uri sistematice
Studii clinice
Variabile
Realitatea
Cercetarea asupra eficientei de tratament face subiectul unui numar mic de articole. Evidence based medicine este considerat un concept ce foloseste baze de date inclusiv studii sistematice de caz pentru a ghida interventii terapeutice. Dovezile trebuie evaluate intr-un context terapeutic efectiv, Ce tip de interventie capata sens pentru mine ca practician?
Clinical Questions
What is the best choice of therapy for my patient? Is this program theoretically sound? Does this therapy program work? How long with the therapy take? Where do I go from here?
Baseline Measurements
A baseline is a measure of response rates in the absence of treatment Baselines Establish a need for treatment Document improvement Allow us to modify if we dont see improvement
Baseline Data
Create a set of exemplars of each of your targets and prepare a recording sheet. Utilize criterion referenced measures.
Always have more than one measurement Check the reliability of the baseline data Select research/clinical design
Research/Clinical Designs
ABA designs Test, treat and test ABAB designs Test, treat, test and treat Time-Series designs Establish stable baseline Begin treatment Measure treatment results Multiple-Baseline designs Have a number of different baselines Each baseline must be independent of the others Only treat one variable
Different judges?
Inter-rater reliability
Sampling Methods
Stratified Sampling
4. Cluster Sampling
5. Convenience Sampling
6. More complex sampling
Variables types
1. Categorical variables (e.g., Sex, Marital Status, income category) 2. Continuous variables (e.g., Age, income, weight, height, time to achieve an outcome) 3. Discrete variables (e.g.,Number of Children in a family) 4. Binary or Dichotomous variables (e.g., response to all Yes or No type of questions)
Scale of Data
1. Nominal: These data do not represent an amount or quantity (e.g., Marital Status, Sex)
2. Ordinal: These data represent an ordered series of relationship (e.g., level of education) 3. Interval: These data is measured on an interval scale having equal units but an arbitrary zero point. (e.g.: Temperature in Fahrenheit) 4. Interval Ratio: Variable such as weight for which we can compare meaningfully one weight versus another (say, 100 Kg is twice 50 Kg)
Independent Variable
The characteristic being observed and/or measured that is hypothesized to influence an event or outcome (dependent variable). NOTE The independent variable is not influenced by the event or outcome, but may cause it or contribute to its variation.
Dependent Variable
A variable whose value is dependent on the effect of other variables (ie., independent variables) in the relationship being studied. Synonyms: outcome or response variable. NOTE an event or outcome whose variation we seek to explain or account for by the influence of independent variables.
Intermediate Variable
A variable that occurs in a causal pathway from an independent to a dependent variable. Synonyms: intervening, mediating NOTES it produces variation in the dependent variable, and is caused to vary by the independent variable. such a variable is associated with both the dependent and independent variables.
Confounding Variable
A factor (that is itself a determinant of the outcome), that distorts the apparent effect of a study variable on the outcome. NOTE such a factor may be unequally distributed among the exposed and the unexposed, and thereby influence the apparent magnitude and even the direction of the effect.
Organizing Data
1. 2. 3. 4. 5. 6. 7. 8. 9. Frequency Table Frequency Histogram Relative Frequency Histogram Frequency polygon Relative Frequency polygon Bar chart Pie chart stem-and-leaf display Box Plot
Frequency Table
Suppose we are interested in studying the number of children in the families living in a community. The following data has been collected based on a random sample of n = 30 families from the community. 2, 2, 5, 3, 0, 1, 3, 2, 3, 4, 1, 3, 4, 5, 7, 3, 2, 4, 1, 0, 5, 8, 6, 5, 4 , 2, 4, 4, 7, 6 Organize this data in a Frequency Table!
Frequency Table
X=No. of Children Count (Freq.)
0 1 2 3 2 3 5 5
Relative Freq.
2/30=0.067 3/30=0.100 5/30=0.167 5/30=0.167
4
5 6 7 8
6
4 2 2 1
6/30=0.200
4/30=0.133 2/30=0.067 2/30=0.067 1/30=0.033
Frequency plot
6 5 4 3 2 1 0 0 1 2 3 4 5 6 7 8 Freq.
Frequency Table
Now suppose we need to construct a similar frequency table for the age of patients with Heart related problems in a clinic. The following data has been collected based on a random sample of n = 30 patients who went to the emergency room of the clinic for Heart related problems. The measurements are: 42, 38, 51, 53, 40, 68, 62, 36, 32, 45, 51, 67, 53, 59, 47, 63, 52, 64, 61, 43, 56, 58, 66, 54, 56, 52, 40, 55, 72, 69.
Frequency Table
Age Groups Frequency Relative Frequency
2/30=0.067
32 -36.99
37- 41.99
42-46.99 47-51.99 52-56.99 57-61.99 62-66.99 67-72 Total
3
4 3 8 3 4 3 n=30
3/30=0.100
4/30=0.134 3/30=0.100 8/30=0.267 3/30=0.100 4/30=0.134 3/30=0.100 1.00
Empirical Rule
For a Normal distribution approximately,
a) 68% of the measurements fall within one standard deviation around the mean
b) 95% of the measurements fall within two standard deviations around the mean c) 99.7% of the measurements fall within three standard deviations around the mean
Prerequisite Skills
Fundamental concepts of measurement
Scales of measurement Distribution, central tendency, variability, probability Disease prevalence and incidence Disease outcomes (eg, fatality rates) Associations (correlation or covariance) Health impact (eg, risk differences and ratios) Sensitivity, specificity, predictive values
Scales of Measure
Nominal qualitative classification of equal value: gender, race, color, city Ordinal - qualitative classification which can be rank ordered: socioeconomic status of families Interval - Numerical or quantitative data: can be rank ordered and sizes compared : temperature Ratio - interval data with absolute zero value: time or space
Variability, Probability
Mean Median Mode Standard deviation Statistical Significance p < .01
Confidence Interval
Do Not Reject Ho
Correct decision
Type II error
Incidence
probability that patient without disease develops disease during interval 0.2% or 2 per 1000 new cases per year
Sensitivity, Specificity
sensitivity = a / (a+c) specificity = d / (b+d)
Patients with disease Test is positive Test is negative Patients without disease
Predictive Value
Positive predictive value = a / ( a+b) Negative predictive value = d / (c+d) Post-test probability of disease given positive test = a / (a+b) Post-test probability of disease given negative test = c / (c+d)
a
c
b
d
InfoRetriever
Calculators: Epidemiology, Diagnostic test
Benefits of Randomization
Prevents the systematic introduction of bias. Minimizes the possibility of allocation bias. Balances prognostic factors for treatment groups.
Confounding Example
Relationship between coffee and pancreatic cancer, BUT Smoking is a known risk factor for pancreatic cancer Smoking is associated with coffee drinking but it is not a result of coffee drinking.
What is confounding?
If an association is observed between coffee drinking and pancreatic cancer
Coffee actually causes pancreatic cancer, or The coffee drinking and pancreatic cancer association is the result of confounding by cigarette smoking.
Randomization: Definition
Random Allocation
known chance receiving a treatment cannot predict the treatment to be given
Types of Randomization
Standard ways: Random number tables (see text) Computer programs NOT legitimate Birth date Last digit of the medical record number Odd/even room number
Types of Randomization
Simple Blocked Randomization Stratified Randomization
Simple Randomization
Randomize each patient to a treatment with a known probability
Corresponds to flipping a coin
Could have imbalance in # / group or trends in group assignment Could have different distributions of a trait like gender in the two arms
Block Randomization
Insure the # of patients assigned to each treatment is not far out of balance Variable block size
An additional layer of blindness
Stratified Randomization
A priori certain factors likely important (e.g. Age, Gender) Randomize so different levels of the factor are balanced between treatment groups Cannot evaluate the stratification variable
Stratified Randomization
For each subgroup or strata perform a separate block randomization Common strata
Clinical center, Age, Gender
Outline
Introductory Statistical Definitions What is Randomization? Randomized Study Design Experimental vs. Observational Non-Randomized Study Design Stat Software, Books, Articles
Parallel Group
Randomize patients to one of k treatments Response
Measure at end of study Delta or % change from baseline Repeated measures Function of multiple measures
Two Scenarios
Study 1
A U.S. study (2000) compared 469 patients with brain cancer to 422 patients who did not have brain cancer. The patients cell phone use was measured using a questionnaire. The two groups use of cell phones was similar.
Study 2
An Australian study (1997) conducted a study with 200 transgenic mice. One hundred were exposed for two 30 minute periods a day to the same kind of microwaves with roughly the same power as the kind transmitted from a cell phone. The other 100 mice were not exposed. After 18 months, the brain tumor rate for the exposed mice was twice as high as that for the unexposed mice.
206
Questions to Consider
How do the two studies differ?
Study 1
Study 2
Questions to Consider
Why do the results of different medical studies sometimes disagree?
Questions to Consider
Suppose a friend recently diagnosed with brain cancer was a frequent cell phone user. Is this strong evidence that frequent cell phone use increases the likelihood of getting brain cancer?
Informal observations of this type are called _____________ _____________. You should rely on reputable research studies, not anecdotes.
Experiment
The researcher assigns experimental conditions (also called treatments) to subjects (also called experimental units) and then observes outcomes on the response variable. Treatments correspond to values of the explanatory variable Example:
Cross-Sectional
Observational studies that take a cross section of the population at the current time
Prospective
Observational studies in which subjects are followed into the future
Disadvantages of Experiments
They can be ____________ to perform on the subjects in which you are interested. It can be difficult to monitor subjects to ensure that they are doing what they are told. They can take many years, even decades, to complete. Results of experiments that use animals do not ______________ to humans. They are unnecessary the question of interest does not involve trying to assess _____________.
Cluster Sampling
It does not require a sampling frame of subjects. It is less ___________ to implement.
Bias in Sampling
A sampling method is _________ if
The sample tends to favor some parts of the population over others. In other words, the results from the sample are not representative of the population.
Types of Bias
Undercoverage
Occurs when a sampling frame leaves out some groups in the population
Nonresponse bias
Occurs when some sampled subjects cannot be reached, refuse to participate or fail to answer some questions
Response bias
Occurs when the subject gives an incorrect response or when the question wording or the way the interviewer asks the questions is confusing or misleading
Randomization
Eliminates ______ that can result when researchers assign treatments to the subjects Balances the group on variables that you know affect the response Balances the group on _________ variables that may be unknown to you
Example
A pharmaceutical company has developed a new drug for treating high blood pressure. To determine the effectiveness of the drug, the company conducted an experiment in which subjects with a history of high blood pressure were treated with the new drug. A later experiment randomly divided subjects with a history of high blood pressure into two groups. Group A was treated with the new drug as before. Group B received the most popular drug on the market at that time. The subjects were unaware of which treatment they received. 60% of the patients in Group A improved, while 63% of the patients in Group B improved. The __________ experiment is better because
Example
To investigate whether antidepressants help smokers to quit smoking, one study used 429 men and women who were 18 or older and had smoked 15 cigarettes or more per day in the previous year. They were all highly motivated to quit and in good health. They were assigned to one of two groups: one group took an antidepressant called Zyban, while the other group did not take anything. At the end of a year, the study observed whether each subject had successfully abstained from smoking.
226
Important Points
Types of studies: Observational studies and experiments Experiments control for lurking variables Sampling designs: SRS, stratified random samples and cluster samples SRS is the preferred method Potential sources of bias: Undercoverage Response bias Nonresponse bias Convenience sampling Voluntary response sampling Elements of good experiments: Control group, randomization and blinding
Important Points
If a group is underrepresented in the sample, we cannot make inference about it. We must be careful when interpreting the results of observational studies. For comparison of several treatments to be valid, you must apply all treatments to similar groups of experimental units. Interesting questions are usually pretty tough to answer. This is due in part to the fact that no single experiment or observational study can determine causation.
Procesul prin care se aplica valorile morale la situatii actuale de viata. [practic]
Individ si Grupuri
Etica: domeniu de studiu care ajuta individul pentru aplicarea propriilor valori si principii pentru a le conduce comportamentul. [individual] Etica: un set de reguli pe care le studiem si aplicam pentru a duce la indeplinire misiunea unei organizatii / institutii. [group]
Etica instututionala
Institutie = grup:
Actioneaza colectiv pentru indeplinirea scopurilor institutionale
Institutie = individ:
Foloseste valori comune cu etica individuala pentru a lua decizii
8. Conflict de Interese
9. Elaborarea si aplicarea consimtamantului Informat 10. Evaluarea prin comitete si institutii 11. Contract 12. Trialuri Clinice
13. Anexe
Metodologia cercetarii
Secventa logica de evenimente din cadrul studiului (protocol) Cum se vor obtine datele? Descriere detaliata pentru fiecare metoda. Pune urmatoarele intrebari:
Cat dureaza interviul/chestionarul/observatia experimentala? Cand (in ce perioada) va avea loc? Unde va avea loc? Participantii vor avea posibilitatea sa intervina in chestionar/studiu? Daca da, ofera detalii.
Participanti
Cine sunt participantii? Organizatii? Indivizi? De ce au fost alesi pentru studiu? (criterii de excludere / includere) Cati sunt? Argumenteaza dimensiunea esantionului
Recrutare
Cum veti obtine o lista a potentialilor participanti? Sistem de contact telefonic Email scrisoare ?
Riscuri si Beneficii
Standarde de aplicare:
Nu exista risc minim anticipat. Participantii vor fi informati despre natura studiului si modalitatii de participare, inclusiv asupra faptului ca se pot retrage oricand. Participantii (si raspunsurile lor privind includerea in studiu) vor fi luate ca atare
Confidentialitate
Este un proces si nu un formular. Formularul este doar documentul care atesta ca procesul de informare liber consimtita a avut loc.
Pentru studii avand ca subiecti copii, consimtamantul scris al parintilor / tutorilor este obligatoriu
Anexe
Populatii vulnerabile
Copii Prizonieri Indivizi cu retard mental Dementa/ Coma/ Starea vegetativa Boli mentale Gravide Pacienti in urgenta
Healthy volunteers
Volunteers may not stand to benefit directly, but could ultimately contribute to development of a new therapy that the participant might then use. Require particularly close monitoring, because they can pose a risk to a volunteer's health or life.
Confidentiality
Unless you guarantee confidentiality you probably wont gain consent and you certainly wont obtain significant data. Once you agree confidentiality then this must be honoured (BUT: our duty of trust / promise is outweighed by our obligation to prevent harm to others). Must ensure that confidentiality is not breached directly (gossiping) or by accident (leaving notes lying around).
Anonymity
Confidentiality is best assured by anonymising collection of data. Anonymity is increasingly difficult as advances in technology are made
Choice of control
The benefits, risks, burdens and effectiveness of a new method should be tested against those of the best current prophylactic, diagnostic, and therapeutic methods. (Helsinki 2000) Balance the need to answer the valuable question in a scientifically rigorous way, while minimizing risks and maximizing benefits to participants.
Vulnerability
There is an order of preference in selecting subjects, for instance, adults before children (Belmont Report)
Exclude vulnerable subjects unless their participation is needed for scientific reasons (CIOMS)
Risks in research
Defining risks
Probability and magnitude Types of risk Uncertainty
Benefits in research
Defining benefits Direct versus secondary benefits
Maximizing benefits
Balancing risks and benefits
Risks are minimized. Risks are justified by anticipated benefits, if any, to the subjects or the importance of the knowledge to be gained Subjects will be selected and treated fairly Informed consent is adequate
Key points
Integrity Fully informed consent Confidentiality Anonymity Respect for children
Balancing principles
Example: Randomized Controlled Trials Balancing the need for a rigorous design with the obligation to maximize benefits and minimize harms
Equipoise Randomization Choice of control
Choice of control
The benefits, risks, burdens and effectiveness of a new method should be tested against those of the best current prophylactic, diagnostic, and therapeutic methods. (Helsinki 2000) Balance the need to answer the valuable question in a scientifically rigorous way, while minimizing risks and maximizing benefits to participants.
Procesul prin care se aplica valorile morale la situatii actuale de viata. [practic]
8. Conflict de Interese
9. Elaborarea si aplicarea consimtamantului Informat 10. Evaluarea prin comitete si institutii 11. Contract 12. Trialuri Clinice
13. Anexe
Anexe
Text Telefonic/email
Exemple de scrisori de consimtamant Ghiduri de observatie clinica Chestionare
Perspective istorice
Tribunalul de razboi de la Nuremberg (1947) judecarea a
23 medici si militari germani care au comis crime de razboi si crime impotriva umanitatii. Teste inadmisibile efectuate cu scop de cercetare pe mii de prizonieri din lagarele de concentrare, fara a obtine consimatamant informat. Tuskegee Syphilis Study (1932-1972) Ca parte componenta a unui proiect de cercetare condus de serviciul public de sanatate din SUA asupra 600 de barbati de culoare, provenind din categorii sociale defavorizate, din care 400 erau infectati cu sifilis, au fost monitorizati timp de 40 ani. Consulturile medicale erau gratuite; totusi, participantii nu au fost informati asupra bolii. Chiar cand a aparut posibilitatea terapiei antibiotice cu penicillina in anii 1950, studiul a continuat pana in 1972, participantii neprimind tratament. In anumite cazuri, cand participantii erau diagnosticati ca avand sifilis de catre alti medici, cercetatorii au intervenit pentru a preveni tratamentul. Multi participanti au murit de sifilis in timpul studiului. Studiul a fost oprit in 1973 de catre Departamentul de Sanatate si Educatie din SUA doar dupa ce a fost mediatizat si a devenit un element politic.
Raportul BELMONT
National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research
Raportul Belmont
Stabileste principiile etice i liniile directoare pentru Protectia Subiectilor Umani in cercetare (aprilie 1979) A stabilit trei principii de baz, care sunt piatra de temelie a reglementrilor care implic protecia subiectilor umani in cercetare
Respect pentru pacient; pastrarea independentei pacientului Cercetarea trebuie sa aduca beneficii starii de sanatate a pacientului Expunerea corecta a avantajelor si dezavantajelor
Perspective istorice
Folosirea Talidomidei - Talidomida a fost
folosita in anii 1950 pentru a combate disgravidia. In perioada utilizarii sale, nu s-a transmis gravidelor faptul ca medicamentul era in curs de investigare, in faza de testare pentru obtinerea autorizatiilor. Dupa ce multe femei din Europa, Canada, si U.S.A au fost tratate, s-a descoperita ca are efecte teratogene, determinand maformatii fetale severe. Talidomida a fost oprita de la comercializare imediat in intreaga lume. Din pacate, aproximativ 12.000 copii s-au nascut cu malformatii severe datorate talidomidei.
Perspective istorice
Experimente de Iradiere(1940s 1960s) Oficiali
din U.S.A au studiat efectele radiatiei prin experimente pe pacienti spitalizati, femei gravide, copii cu intarziere mentala, cadre militare sau puscariasi. Putini dintre participantii la experimente au dat consimtamant informat. Majoritatea nu stiau ca sunt expusi la materiale radioactive. Oficialii proiectului Manhattan au autorizat experimente din timpul razboiului pentru a stabilii standarde de sanatate si siguranta pentru sutele de muncitori din fabricile de armament atomic.
Eventimente Santinela
Crime de razboi naziste
Experimente de iradiere
Actul National de Cercetare (1974) care a aparut ca urmare a raspunsului la Studiului Tuskegee sifilis, instaureaza necesitatea ca subiectii umani sa fie protejati si sa beneficieze de achizitiile cele mai recente in cercetare, fiind baza de pornire pentru Raportul Belmont.
http://www.wma.net/en/30publications/10policies/b3/index.html
Declaration of Helsinki
World Medical Association, 1964. Ultima evaluare - 2008 Cercetarea cu subieci umani se justific doar atunci cnd gradul de risc pentru subieci nu depete importana cunotinelor care urmeaz s fie dobndite. DH este baza pentru normele de buna practica clinica utilizate n prezent.
Declaratia de la Helsinki
Probleme abordate: Cercetarea clinica ar trebui s se bazeze pe experimente de laborator (in vitro) i animale (in vivo) Protocoalele experimentale trebuie s fie revizuite de ctre un comitet independent Acordul de participare la cercetare in scris-consimmntul informat Cercetrile efectuate de ctre persoane fizice calificate medical / si stiintific Riscurile i beneficiile studiului Impactul / respectul asupra vieii private a persoanei Publicarea rezultatelor cercetrii
Metodologia cercetarii
Participanti
Cine sunt participantii? Organizatii? Indivizi? De ce au fost alesi pentru studiu? (criterii de excludere / includere) Cati sunt? Argumenteaza dimensiunea esantionului
Recrutare
Email
scrisoare ?
Riscuri si Beneficii
Standarde de aplicare:
Nu exista risc minim anticipat. Participantii vor fi informati despre natura studiului si modalitatii de participare, inclusiv asupra faptului ca se pot retrage oricand. Participantii (si raspunsurile lor privind includerea in studiu) vor fi luate ca atare
Confidentialitate
Formularul este doar documentul care atesta ca procesul de informare liber consimtita a avut loc.
Pentru studii avand ca subiecti copii, consimtamantul scris al parintilor / tutorilor este obligatoriu
Populatii vulnerabile
Copii Prizonieri Indivizi cu retard mental Dementa/ Coma/ Starea vegetativa Boli mentale Gravide Pacienti in urgenta
Confidentialitate
Fara garantarea confidenialitatii, nu se poate semna acordul de consimtamant. Odat ce suntei de acord cu confidenialitatea, atunci acest lucru trebuie s fie onorat (DAR: este de datoria noastr sa prevenim efectele negative pentru alii). Trebuie s se asigure c nu este nclcata confidenialitatea n mod direct (brfe) sau de accident (lsnd notite despre caz, bilete de iesire, foi de observatie).
Anonimitatea
Confidentialitatea este asigurata prin codificarea anonima a colectiei de date.
Anonimizarea este din ce in ce mai dificila, pe masura progresului tehnologic
Conflictul de Interese
O situaie n care considerente financiare sau de alt natur cu caracter personal pot influenta, sau poate fi perceput de ctre alii ca generatoare de eroare pentru judecata profesional.
Conflict de Interese
Financiar
Actiuni la firma farmaceutica, consultant, speaker
Non-financiare
Recunoatere in domeniu, dorina de a avansa teoria cuiva Nu suntem n msur s eliminam conflictele de interes, dar exist i alte opiuni: reducerea, evitarea sau prezentarea explicita a acestora
Conflict de Interese
De obicei, rezult din rolul dublu al unui cercettor De exemplu, un profesor / cercetator care doreste s colecteze date de la proprii studenti, sau un alt tip de relaie n care cercettorul are un rol de evaluare n raport cu participanii
Potenialii participani pot simti o presiune de a participa ce rezult din relaia de putere dintre profesor / student i nu se simt foarte confortabil sa refuze participarea
Conflict de Interese
Impactul asupra drepturilor i bunstrii persoanelor implicate in cercetare Existenta unor conflicte de interese poate duce la erori in metodologia studiului si pierderea ncrederii publicului
Impactul asupra integritii datelor depuse la autoritile de reglementare i reviste
Tipuri de date
Body temperature Body weight Room temperature, humidity Food/water use Animal behavior (e.g., sleeping, aggression) Assay data
Pastrarea datelor
Caiet de laborator semnat si datat Scris LIZIBIL Fara pasta corectoare Se taie cu o linie, se semneaza si se dateaza. Fara Postit (sticky notes). Fara pagini albe.
Author Requirements*
Authorship credit should be based on: 1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; and 2) drafting the article or revising it critically for important intellectual content; and 3) final approval of the version to be published. Authors should meet conditions 1, 2, and 3.
*Intl Comm of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication. November 2009.
http://www.icmje.org/ethical_1author.html
Authorship
Those credited with authorship should be able to take public responsibility for the research.
Authorship*
Acquisition of funding, collection of data, or general supervision of the research group, alone, does not justify authorship.
*Intl Comm of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication. November 2009.
Authorship
Decide up front who will work on the manuscript and what the order of authors will be.
(Not all people working on the project will meet authorship requirements).
Research Misconduct
Fabrication (creating data) Falsification (changing data) Plagiarism (using anothers words or ideas without giving them credit).
This includes cutting and pasting from the Internet.
Propels further generation of bad data as the initial data foundation is bad
Misconduct Research
Survey of 3247 researchers:
28% admitted to poor record keeping 16% admitted to changing the design, methodology, or results of a study in response to pressure from their funding source 15% admitted to dropping observations/data points based on a gut feeling 10% admit to giving authorship to people who didn't earn it
Identification
Make sure your animals are clearly identifiable, whether singularly or in groups.
Options include cage labels, neck labels, tattoo, microchip, etc.
Consider the animal species Housing should consider size of animal, temperature, bedding needs, food, clean water, light, noise, humidity, contact with other animals, air exchange, vibration, etc. Keep the cages clean, and the animals free from harm from other animals. (This includes avoiding crowding within a cage).
If possible, before starting your project, CONDITION your animals to their environment, procedures, and research personnel.
Pain/Suffering
An animal with signs of pain or distress not predicted in the protocol, must have the pain or distress alleviated promptly. Alleviation of such pain or distress must take precedence over completing a project. If this is not possible the animal must be euthanized without delay.
People are the means to developing useful knowledge; and are thus at risk of exploitation
CONCLUZII
Etica n cercetarea ncepe cu cererea de finanare
Se aplic tuturor celor implicai n procesul de cercetare Se ncheie cu publicarea i consecintele (clinice si stiintifice) acesteia